Susquehanna International Group’s Biocept, Inc. BIOC Stock Holding History

Susquehanna International Group’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-927	Closed	-$64K	–	14377
2022 Q1	$64K	Sell	927 -693	-43%	-$54.4K	﹤0.01%	12194
2021 Q4	$176K	Sell	1,620 -643	-28%	-$74.1K	﹤0.01%	11600
2021 Q3	$272K	Buy	2,263 +160	+8%	+$18.7K	﹤0.01%	10815
2021 Q2	$264K	Buy	2,103 +216	+11%	+$29.2K	﹤0.01%	11048
2021 Q1	$288K	Buy	+1,887	New	+$343K	﹤0.01%	10696
2015 Q4	–	Sell	-1	Closed	-$86K	–	10136
2015 Q3	$86K	Buy	+1	New	+$62.5K	﹤0.01%	9203
2015 Q2	–	Hold	0	–	–	–	9956

Susquehanna International Group's BIOC Position: Q4 2023 in Review

Susquehanna International Group sold out of Biocept, Inc. (BIOC) in Q4 2023, closing a stake of 10,406 shares — an estimated $13K sold.

Susquehanna International Group first reported a position in BIOC in Q3 2015 and held it in 16 quarters. The position peaked at $1.7M in Q1 2017. 0 funds tracked by Wall St. Rank hold BIOC as of Q4 2023.

Susquehanna International Group reported no remaining Biocept, Inc. position as of Q4 2023 after selling out during the quarter.
Susquehanna International Group sold 10,406 Biocept, Inc. shares in Q4 2023, an estimated $13K.
Susquehanna International Group first reported a position in Biocept, Inc. in Q3 2015 and held it in 16 quarters.
Susquehanna International Group's Biocept, Inc. position peaked at $1.7M in Q1 2017.
0 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.